non-vasospastic subjects
Showing 51 - 75 of >10,000
Advanced NSCLC Trial in China (KN046 (Recombinant Humanized PD-L1/CTLA-4 Bispecific Single Domain Antibody Fc Fusion Protein
Enrolling by invitation
- Advanced Non-small Cell Lung Cancer
- KN046 (Recombinant Humanized PD-L1/CTLA-4 Bispecific Single Domain Antibody Fc Fusion Protein Injection)
- Axitinib
-
Hefei, Anhui, China
- +5 more
Oct 26, 2022
Non-radiographic Axial Spondyloarthritis Trial (SHR0302, SHR0302 )
Recruiting
- Non-radiographic Axial Spondyloarthritis
- SHR0302
- SHR0302 placebo
-
Beijing, Beijing, ChinaBeijing Hospital
Sep 1, 2022
Vulvovaginal Candidiasis, Candida Infection, Vaginal Candidiasis Trial in New Delhi (Non-interventional study)
Recruiting
- Vulvovaginal Candidiasis
- +2 more
- Non-interventional study
-
New Delhi, Vasant Vihar, IndiaAWINSA
Jun 8, 2023
B-cell Non-Hodgkin Lymphoma (B-NHL) Trial in Austin (UCART20x22, CLLS52)
Recruiting
- B-cell Non-Hodgkin Lymphoma (B-NHL)
- UCART20x22
- CLLS52
-
Austin, TexasSarah Cannon - St. David South Austin Medical Center
Dec 8, 2022
Non-Alcoholic Fatty Liver Disease Trial in United States (ALT-801, Placebo)
Active, not recruiting
- Non-Alcoholic Fatty Liver Disease
- ALT-801
- Placebo
-
Montclair, California
- +12 more
Oct 11, 2022
Back Muscles With Low Back Pain Patients
Recruiting
- Chronic Non-specific Low Back Pain
- Ultrasonography imaging and Hand-held dynamometer (HHD)
-
Cairo, EgyptCairo University
Oct 9, 2023
NSCLC Trial (KB-GDT-01)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- KB-GDT-01
- (no location specified)
Sep 29, 2023
Advanced NSCLC Trial in Jilin (pemetrexed, Cetuximab, cis-platinum)
Not yet recruiting
- Advanced Non-Small Cell Lung Cancer
- pemetrexed
- +5 more
-
Jilin, Changchun, ChinaJilin Province Cancer Hospital
Aug 15, 2022
Nonalcoholic Steatohepatitis (NASH), Primary Sclerosing Cholangitis (PSC), Systemic Sclerosis (SSc) Trial in Tel Aviv (CM-101,
Completed
- Nonalcoholic Steatohepatitis (NASH)
- +2 more
- CM-101
- Placebo
-
Tel Aviv, IsraelTel Aviv Sourasky Medical Center
Sep 7, 2023
Non Small Cell Lung Cancer, NSCLC, Lung Cancer Trial in Port Saint Lucie, Greenville (BL-B01D1)
Recruiting
- Non Small Cell Lung Cancer
- +2 more
-
Port Saint Lucie, Florida
- +1 more
Aug 11, 2023
Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial (AFNT-211)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- +4 more
- (no location specified)
Oct 23, 2023
Obstructive Pulmonary Function, Restrictive Pulmonary Function Trial in Winter Park, Baltimore, Berlin (single dose (100 mg) of
Not yet recruiting
- Obstructive Pulmonary Function
- Restrictive Pulmonary Function
- single dose (100 mg) of ASA
- single dose (162 mg) of non-enteric-coated chewable aspirin tablets
-
Winter Park, Florida
- +2 more
Nov 21, 2022
Atrial Fibrillation Trial in Tbilisi (Left Atrial Appendage Closure)
Recruiting
- Atrial Fibrillation
- Left Atrial Appendage Closure
-
Tbilisi, GeorgiaTbilisi Heart and Vascular Clinic
Sep 29, 2022
Cardiac Output Measurements, Healthy Subjects Trial in Leuven (Pulsify sensor, State-of-the-art ultrasound equipment)
Completed
- Cardiac Output Measurements
- Healthy Subjects
- Pulsify sensor
- State-of-the-art ultrasound equipment
-
Leuven, Vlaams-Brabant, BelgiumUZ Leuven
Feb 8, 2023
Advanced NSCLC Trial (SHR-A1811 & Pyrotinib/SHR-A1811 & SHR-1316)
Not yet recruiting
- Advanced Non-small Cell Lung Cancer
- SHR-A1811 & Pyrotinib/SHR-A1811 & SHR-1316
- (no location specified)
Jul 29, 2022
Hypercholesterolemia Trial (HSK31679 low dose, HSK31679 medium dose, HSK31679 high dose)
Not yet recruiting
- Hypercholesterolemia
- HSK31679 low dose
- +4 more
- (no location specified)
Mar 20, 2023
Liver Fat, Liver Fibrosis, Glycemic Control Trial (Ertugliflozin 5 mg, 15mg)
Not yet recruiting
- Liver Fat
- +5 more
- Ertugliflozin 5 mg, 15mg
- (no location specified)
Nov 30, 2022
Breast Cancer, Nonsmall Cell Lung Cancer Trial in Beijing ([14C]GB491)
Completed
- Breast Cancer
- Nonsmall Cell Lung Cancer
-
Beijing, Beijing, ChinaBeijing GoBroad Boren Hospital
May 5, 2023
NSCLC Trial in Cologne (observational, non-interventional)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- observational, non-interventional
-
Cologne, GermanyUniversity Hospital Cologne
Jul 3, 2023
Advanced Solid Tumor Trial in Guangzhou (NWY001)
Not yet recruiting
- Advanced Solid Tumor
- NWY001
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Cancer
Aug 6, 2023